LncRNA NCK1-AS1-mediated regulatory functions in human diseases
Clin. transl. oncol. (Print)
; Clin. transl. oncol. (Print);25(2): 323-332, feb. 2023.
Article
em En
| IBECS
| ID: ibc-215932
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
Disease development requires the activation of complex multi-factor processes involving numerous long noncoding RNAs (lncRNAs), which describe non-protein-coding RNAs longer than 200 nucleotides. Emerging evidence indicates that lncRNAs act as essential regulators that perform pivotal roles in the pathogenesis and progression of human diseases. The mechanisms underlying lncRNA involvement in diverse diseases have been extensively explored, and lncRNAs are considered powerful biomarkers for clinical practice. The lncRNA noncatalytic region of tyrosine kinase adaptor protein 1 (NCK1) antisense 1 (NCK1-AS1), also known as NCK1 divergent transcript (NCK1-DT), is encoded on human chromosome 3q22.3 and produces a 27,274-base-long transcript. NCK1-AS1 has increasingly been characterized as a causative agent for multiple diseases. The abnormal expression and involvement of NCK1-AS1 in various biological processes have been associated with several diseases. Further exploration of the mechanisms through which NCK1-AS1 contributes to disease development and progression will provide a foundation for potential clinical applications of NCK1-AS1 in the diagnosis and treatment of various diseases. This review summarizes the current understanding of the various functions and mechanisms through which NCK1-AS1 contributes to various diseases and the clinical application prospects for NCK1-AS1 (AU)
Palavras-chave
Buscar no Google
Coleções:
06-national
/
ES
Base de dados:
IBECS
Assunto principal:
Progressão da Doença
/
Proteínas Adaptadoras de Transdução de Sinal
/
RNA Longo não Codificante
Idioma:
En
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2023
Tipo de documento:
Article